X | ||||||||||
- Definition Amount of expenses incurred for execution of agreement. No definition available.
|
X | ||||||||||
- Definition Represents the number of agreement entered for services perform due diligence, tax diligence and structuring services associated with the Merger Agreement. No definition available.
|
X | ||||||||||
- Definition Number of shares unvested. No definition available.
|
X | ||||||||||
- Definition Represents the number of Sponsor Lockup Securities. No definition available.
|
X | ||||||||||
- Definition Percentage of fee payable on securities sold. No definition available.
|
X | ||||||||||
- Definition Represents the percentage of Sponsor Lockup Securities held. No definition available.
|
X | ||||||||||
- Definition Represents the period after closing of the agreement. No definition available.
|
X | ||||||||||
- Definition Represents the threshold epriod after closing of the agreement. No definition available.
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|